Crinetics Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Crinetics Pharmaceuticals Inc
CIK #0001658247
EDGAR Form CIK 2011 - 2026
10-K [0001658247]
10-Q [0001658247]
3 [0001658247]
4 [0001658247]
5 [0001658247]
8-K [0001658247]
D [0001658247]
SC 13D [0001658247]
SC 13G [0001658247]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Crinetics Pharmaceuticals Inc [2026-04-29]
Price T Rowe Associates Inc /MD/ Crinetics Pharmaceuticals Inc [2024-11-14]
Wellington Management Group LLP Crinetics Pharmaceuticals Inc [2024-11-08]
EcoR1 Capital LLC Crinetics Pharmaceuticals Inc [2024-03-11]
Vanguard Group Inc Crinetics Pharmaceuticals Inc [2024-02-13]
FMR LLC Crinetics Pharmaceuticals Inc [2024-02-09]
State Street Corp Crinetics Pharmaceuticals Inc [2024-01-24]
Point72 Asset Management LP Crinetics Pharmaceuticals Inc [2023-09-18]
Braidwell LP Crinetics Pharmaceuticals Inc [2023-02-14]
Wellington Management Group LLP Crinetics Pharmaceuticals Inc [2023-02-06]
View All
Form 3/4/5 Subject 2011 - 2026
Vivaldi Coelho Rogerio
Crinetics Pharmaceuticals Inc
Bedrosian Camille L
Wierenga Wendell
Okey Stephanie
Deardorf Caren
Fust Matthew K
Nichols Weston
Struthers Richard Scott
Knight Jeff E
Betz Stephen F
Schilke Tobin
Kalofonos Isabel
Pizzuti Dana
Wierenga Wendall
Wilson Marc
Hassard James
Krasner Alan Seth
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Madan Ajay
Kaldor Stephen W
Vivo Capital Surplus Fund VIII LP
Vivo Capital VIII LLC
Vivo Capital Fund VIII LP
Vivo Opportunity LLC
Vivo Opportunity Fund LP
5AM Ventures IV LP
5AM Partners IV LLC
5AM Co-Investors IV LP
Schwab Andrew J
Diekman John D
Rocklage Scott M
Nielsen Jack
Versant Ventures V LLC
Versant Venture Capital V LP
Versant Affiliates Fund V LP
Versant Ventures V Canada LP
Versant Venture Capital V Canada LP
Versant Ophthalmic Affiliates I LP
Vivo Capital LLC
Freeman Mason
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-16 Sell 4,241 $37.77 160,183
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-16 Sell 5,950 $37.11 220,804
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-16 Sell 3,961 $37.77 149,607
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-16 Sell 6,371 $37.11 236,428
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-16 Sell 8,785 $37.77 331,809
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-16 Sell 13,196 $37.11 489,704
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-12 Sell 523 $36.77 19,231
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-12 Sell 4,477 $36.08 161,530
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-03 Sell 3,000 $39.67 119,010
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-03-03 Sell 6,713 $39.67 266,305
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
2026-02-23 Grant 55,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-02-23 Grant 32,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
2026-02-23 Grant 47,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
2026-02-23 Grant 55,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-02-23 Grant 34,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-02-23 Grant 62,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
2026-02-23 Grant 50,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-02-23 Grant 34,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
2026-02-23 Grant 228,000 $0.00
Crinetics Pharmaceuticals Inc CRNX
Common Stock
2026-02-23 Grant 30,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com